Exenatide could alleviate oxidative stress damage and suppress the NLRP3 inflammasome by promoting the mitophagy pathway in the liver, thereby providing a protective role for the liver in NAFLD and diabetes within C57BL/6 mice (Shao et al., 2018). Here, NLRP3 is linked to metabolic dysfunction-associated steatotic liver disease.